BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 24683821)

  • 1. [Two cases of primary malignant melanoma of the larynx: a rare pathology].
    Chaput B; De Bonnecaze G; Vergez S; Garrido I; Grolleau JL; Benlyazid A
    Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):105-8. PubMed ID: 24683821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary malignant melanoma of the larynx. A case report.
    Duwel V; Michielssen P
    Acta Otorhinolaryngol Belg; 1996; 50(1):47-9. PubMed ID: 8669272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of relevant factors causing postoperative recurrence of laryngeal cancer after partial laryngectomy].
    Liu C; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):377-81. PubMed ID: 24054016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal pleomorphic rhabdomyosarcoma.
    Schrock A; Jakob M; Zhou H; Bootz F
    Auris Nasus Larynx; 2007 Dec; 34(4):553-6. PubMed ID: 17481838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary malignant melanoma of the larynx].
    Szmeja Z; Kruk-Zagajewska A; Kaczmarek J; Zieliński L; Majewski P
    Otolaryngol Pol; 2000; 54(2):173-6. PubMed ID: 10961077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysphonia following malignant melanoma and poly-chemotherapy].
    Skodacek D; Kurz K
    Laryngorhinootologie; 2010 Feb; 89(2):98-9. PubMed ID: 19718618
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of intraoperative surgical margin study in supracricoid laryngectomy.
    Nakayama M; Okamoto M; Iwabuchi K; Mikami T; Seino Y
    Auris Nasus Larynx; 2011 Apr; 38(2):261-5. PubMed ID: 20729021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synovial sarcoma, a rare tumor of the larynx. Case report and differential diagnostic considerations].
    Danninger R; Humer U; Stammberger H
    Laryngorhinootologie; 1994 Aug; 73(8):442-4. PubMed ID: 7945664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
    McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
    Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clear-cell carcinoma of the larynx: review of the literature apropos of a case].
    Sahraoui S; Belaabidia B; Acharki A; Sqali S; Kahlain A
    Cancer Radiother; 2001 Apr; 5(2):155-8. PubMed ID: 11355580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant melanoma of the epiglottis: a rare presentation.
    Durai R; Hashmi S
    Ear Nose Throat J; 2006 Apr; 85(4):274-7. PubMed ID: 16696365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of laryngeal adenoid cystic carcinoma].
    Serafini I; Lucioni M; Bittesini L; Dei Tos AP; Della Libera D
    Acta Otorhinolaryngol Ital; 1991; 11(1):13-24. PubMed ID: 1654724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subglottic presentation of a rare tumor: primary or metastatic? Primary mucosal melanoma of the subglottic larynx.
    Zaghi S; Pouldar D; Lai C; Chhetri DK
    JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):739-40. PubMed ID: 23868432
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant radiotherapy for primary mucosal malignant melanoma of the larynx.
    Asare-Owusu L; Shotton JC; Schofield JB
    J Laryngol Otol; 1999 Oct; 113(10):932-4. PubMed ID: 10664714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
    Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
    J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of paratracheal lymph node metastases.
    Plaat RE; de Bree R; Kuik DJ; van den Brekel MW; van Hattum AH; Snow GB; Leemans CR
    Laryngoscope; 2005 May; 115(5):894-8. PubMed ID: 15867661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.